1k
anyone else notice triple agonist kicking in around week 65
anyone else notice triple agonist kicking in around week 65. Numbers below. Ask me the boring questions, they are the useful ones. Kept a log specifically because there…
u/kofi_balogun
Contributes reviews on supplier material. Based in Lagos.
member · joined 13 Apr 2025
1,096post karma
8,409comment karma
1submissions
55comments
Overview — page 2 of 2
comment on 3 months in and triple agonist is still the thing I get wrong in c/retatrutide · 0 points · 1 year ago
Same read.
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.
comment on [Question] how do you actually verify Mounjaro in c/tirzepatide · 0 points · 1 year ago
Research-use-only material is not approved for human use. Anything in this thread about how a research vial "should" titrate is a discussion about chemistry, not a plan.
comment on anyone else notice triple agonist kicking in around week 65 in c/retatrutide · 54 points · 1 year ago
Which phase 2 arm are you quoting, and at what week?
comment on anyone else notice triple agonist kicking in around week 65 in c/retatrutide · 75 points · 1 year ago
How fast was the escalation?
Disagree with this specific inference. A 48-week readout does not tell you the shape of the curve after it.
comment on baseline labs are the most under-discussed thing on this board in c/bloodwork · 476 points · 2 years ago
Substantial weight loss independently moves lipids, liver enzymes and several other markers. Attributing a change to a compound while losing weight is confounded by design.
comment on tirzepatide: the version I wish someone had shown me in week 1 in c/tirzepatide · 1 points · 2 years ago
SURMOUNT-1 landed around 21% at 72 weeks on the top arm
comment on [Discussion] can we stop arguing about ApoB until somebody posts a number in c/bloodwork · 21 points · 2 years ago
Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.
comment on [Lab] 2th independent test on BCH — 97.8% on a claimed 97.5%, and the trend is the interesting part in c/retatrutide · 845 points · 2 years ago
Small fix — three receptors, not two. GLP-1, GIP and glucagon, and the third one is the reason this compound gets its own board.
comment on retatrutide: what the trials say vs what this community says in c/retatrutide · 10 points · 2 years ago
the TRIUMPH programme is still running, so anything definitive is premature
comment on anyone else notice baseline labs kicking in around week 7 in c/bloodwork · 1 points · 2 years ago
Small fix — a reference interval is not a treatment target, and the post above uses them interchangeably.
comment on how much of what we believe about A1c actually comes from ferritin threads in c/bloodwork · 300 points · 2 years ago
Same lab as the previous draw?
comment on [Results] 66 weeks, 24kg, and triple agonist was the hard part in c/retatrutide · 4 points · 2 years ago
This. The phase 2 result was genuinely large and it was also 48 weeks in a few hundred people.
comment on week 19 check-in — 9kg down, early fullness manageable, one thing confusing me in c/retatrutide · 898 points · 2 years ago
Right, and it bears repeating that nothing here is approved anywhere and research material is not for human use.
comment on [Results] 45 weeks on 10mg, full numbers, ask me anything boring in c/retatrutide · 1 points · 2 years ago
comparing reta phase 2 to sema phase 3 is comparing different things
comment on [Results] 45 weeks on 10mg, full numbers, ask me anything boring in c/retatrutide · 5 points · 2 years ago
Sent a vial to VendorInvestigate out of curiosity. Result was 99.4% against a claimed 98.5%, which is the first independent number I had seen for this compound anywhere.